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Table 2
Predictors of JSN dichotomized at >0.2 mm/24 months
Predictor Area under ROC
curve (AUC)
p-value q-value (FDR)
Plasma tMMP-9 0.66 0.002 0.011
Plasma IL-1Ra 0.63 0.017 0.026
PBL COX2 gene expression 0.65 0.005 0.011
Multivariate predictive model 0.74 <0.001 _
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and IL-1b, are produced by OA joint tissues, where they may
contribute to disease pathogenesis. In the current studies we
examined whether inﬂammatory events occurring within joint
tissues could be reﬂected outside the joint in the plasma and
peripheral blood leukocytes (PBLs) of patients with OA.
Methods: We recruited 178 SKOA patients (mean age 63.09  10.3,
mean BMI 26.5  3.6) as part of an NIH-funded 24 month
prospective study. 144 patients completed the study and had x-ray
and blood samples at baseline and 24 months. Standardized semi-
ﬂexed radiographs were scored for overall KL grade and joint space
width (JSW) by the same radiologist. Plasma samples were
assayed for MMP2, 9, IL-1b, TNFa, VEGF and IL-1Ra using the
highly sensitive Erenna Immunoassay system (Singulex, Inc). PBL
gene expression of COX-2, IL-1b and TNFa was determined by gene
array.
Results: Using support vector machine methodology, we con-
structed a combinatorial biomarker of OA based on microarray
data. Among these probe sets representing PGE2 synthase and
COX-2 could classify the case vs. control with 0.83 mean AUC (95%
CI 0.72- 0.95) (AUC: area under ROC curve), as estimated by 10-fold
cross-validation procedure. Further cluster analysis also revealed
two distinct subclasses among these OA patients: those (OA1) with
increased expression (>4-fold) of inﬂammatory genes (e.g, IL-1b,
COX-2) compared to controls and those OA patients (OA2) with
expression comparable to controls. Overexpression of
inﬂammatory genes were validated using QPCR (p<0.0001). Based
on QPCR, we dichotomized OA patients based on median
expression level of IL-1b, COX-2, and TNFa; Table 1 shows that
patients whose PBL exhibited an inﬂammatory phenotype (OAIL-1,
OACOX-2, or OATNFa) were at higher risk for rapid disease progres-
sion (JSN). In baseline association studies, patients in the OAIL-1
group also exhibited: a) higher WOMAC pain, stiffness and
decreased physical function (p<0.0001), b) higher VAS pain
(p<0.001) than OAnl group. To determine whether OA PBLs were
“primed”, we measured PGE2 production by whole blood PBL
cultured (24h) ex vivo. PGE2 in controls did not change, while
levels in OA patients increased 300% over baseline (p<0.01). Of
interest, the mean plasma PGE2 levels in OA patients was two-fold
higher than in controls (72  33 vs. 163  64 pg/ml, p¼0.001). We
next analyzed the 144 completer patients with regard to
radiographic progression by JSN. We assessed the following 10
clinical, protein, and genomic predictors: VAS pain, WOMAC score,
plasma PGE2, tMMP-9, VEGF, IL-1Ra, PBL IL-1b expression, TNFa
and COX2 expression. Among these, three biomarkers (plasma
tMMP-9 and IL-1ra; and PBL COX-2 expression) univariately were
signiﬁcant predictors of JSN dichotomized at >0.2 mm/24 months,
according to Delong's test for comparing areas under ROC curve at
0.05 a-level. When these three statistically signiﬁcant
predictors were combined into a multivariate predictive model
using kernel ridge regression, the resulting predictivity of JSN
increased to 0.74 AUC (95% CI [0.63; 0.84] AUC, p ¼ <0.001)
[Table 2].
Conclusions:. The data indicate that inﬂammatory events
within joint tissues of patients with SKOA are reported in
peripheral blood. This includes increased inﬂammatory
mediator gene expression (COX-2, IL-1b and TNFa) by PBLs in
a subset of patients with SKOA, which identiﬁes a cohort of patients
with increased pain who are at increased risk for disease
progression. These transcriptome and plasma protein/lipid signals
of local joint inﬂammation merit further study as potential
prognostic biomarkers for OA disease progression.Table 1
PBL IL-1, COX-2, and TNFa over-expression (QPCR) are associated with increased joint sp
JSW (mm) knee medial IL-1 (PBL mRNA) COX-2 (PB
OAIL-1 (n¼73) OAnl (n¼71) p value OACOX-2 (n
baseline 3.44 (1.80) 3.07 (1.71) 0.15 3.30 (1.89)
24 month 2.89 (1.83) 2.99 (1.72) 0.74 2.78 (1.83)
JSN (mm) 0.55 (0.93) 0.07 (1.01) 0.007 0.52 (1.03)50
SYNERGISTIC CHONDROPROTECTIVE EFFECT OF CHONDROTIN
SULFATE AND GLUCOSAMINE: A PHARMACOPROTEOMIC STUDY.
V. Calamia 1, J. Mateos 1, P. Fernández-Puente 1, L. Lourido 1,
E. Montell 2, J. Vergés 2, C. Ruiz-Romero 1, F.J. Blanco 1. 1 INIBIC-CHUAC.
ProteoRed/ISCIII. Proteomic Group. Rheumatology Div., A Coruña, Spain;
2 Pharmacological Res. Unit, Scientiﬁc Med. Dept., Bioibérica, S.A.,
Barcelona, Spain
Purpose: To assess the synergistic chondroprotective effect of chon-
droitin sulphate (CS) and glucosamine hydrochloride (GH) in modifying
cartilage extracellular matrix metabolism by chondrocytes secreted
proteins analysis using iTRAQ technique.
Methods: Cartilage obtained from patients undergoing joint
replacement was provided by the Tissue Bank and the Autopsy
Service at CHU A Coruña. The study was approved by the local Ethics
Committee. Chondrocytes released from osteoarthritic (OA) cartilage
by enzymatic digestion were recovered and cultured in basic DMEM
supplemented with antibiotics and 10% FBS. When conﬂuence was
reached, OA chondrocytes were treated with CS alone and in
combination with GH (both at 200mg/mL). 48 hours later, condi-
tioned media were collected and their proteins were concentrated
and quantiﬁed. Trypsin digestion and labelling with isobaric tags
using iTRAQ reagents were performed. Then, peptides from the four
conditions (untreated, CS-treated, GH-treated, and CS+GH-treated)
were mixed, separated and analyzed by nanoscale reversed-phase
liquid chromatography coupled to mass spectrometry (nLC-MALDI-
MS/MS). The identiﬁcation and quantiﬁcation of proteins (by calcu-
lating the different iTRAQ tags intensities for each peptide) was
carried out with Protein Pilot 3.0 software. CS and GH were provided
from Bioibérica, S.A. (Barcelona, Spain).
Results: Database search (UniprotKB/Swissprot) allowed us the iden-
tiﬁcation of 143 different proteins in the OA chondrocyte secretome. For
biological and functional analysis we considered only those proteins
with a probability score higher than 95%, and a ratio 1.2 or 0.8.
Finally, 17 secreted proteins presented statistically signiﬁcant differ-
ences (p0.05) between untreated and treated samples: 13 were
increased and 4 decreased (see table 1). CS alone modulated 3 proteins,
while in combination with GH modulated 7 proteins. Most of the
altered proteins are cartilage ECM components (59%), such as collagens
and proteoglycans. Interestingly, we found increased LTBP2, thus sug-
gesting a possible effect of the combined formulation in inhibiting
osteophyte formation and ﬁbrosis induced by high amounts of TGF-beta
into OA joints.
Conclusions: We have carried out the ﬁrst pharmacoproteomic study
based on peptides labelling with 4 isobaric tags (iTRAQ) to study the
effect of CS, alone and in combination with GH, on chondrocytes
secretome. Our ﬁndings conﬁrm the potential synergistic chon-
droprotective effect of chondrotin sulfate and glucosamine
hydrochloride.ace narrowing (JSW) at 24 months. Values are expressed as mean (SD).
L mRNA) TNFa (PBL mRNA)
¼74) OAnl (n¼70) p value OATNFa(n¼74) OAnl (n¼70) p value
3.2 (1.63) 0.35 3.20 (1.89) 3.31 (1.64) 0.7097
3.11 (1.7) 0.54 2.61 (1.87) 3.29 (1.60) 0.0198
0.091 (0.92) 0.007 0.59 (0.98) 0.02 (0.93) 0.0004
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QUANTITATIVE PROTEOMICS OF DIFFERENT ZONES IN HUMAN
ARTICULAR CARTILAGE REVEALS UNIQUE PATTERNS OF PROTEIN
DISTRIBUTION
C. Müller 1, A. Khabut 2, A. Aspberg 1, D. Heinegård 2, J. Dudhia 3,
P. Önnerfjord 2. 1Dept. of Biology, Copenhagen, Denmark; 2Clinical Sci.,
Lund, Sweden; 3Vet. Clinical Sci., London, United Kingdom
Purpose: The progress in proteomics technology development during
the last decade has made tissue proteomics available also for the study
of extracellular matrices such as cartilage and bone. We have used
quantitative proteomics used for a detailed study of different zones in
articular cartilage to increase our knowledge of structure in relation to
cartilage biology.
Methods: Our gel-free proteomics approach includes tissue extraction,
digestion by trypsin and tagging of peptides with ITRAQ for quantiﬁca-
tion followed by 2D LC-separations coupled to tandem mass spectrom-
etry for their identiﬁcation and quantiﬁcation. The tissuewas sliced from
top to bottom in 10mm thin sections and the full thickness cartilage was
divided into 9 pools including superﬁcial, intermediate and deep zones.
Results: Previous known distributions of e.g. superﬁcial zone protein
(lubricin) were conﬁrmed but also novel ﬁndings were observed e.g.
asporin which was predominantly seen in the top layers. In total
approximately 200 proteins were identiﬁed and quantiﬁed showing
different patterns.
Conclusions: As an alternative to immunohistochemistry we used
proteomics technology to study the protein abundance across full
thickness articular cartilage. The advantage of this approach is that it
allows multiple targets to be studied simultaneously and that it is
independent of antibody availability. Other advantages include unam-
biguous identiﬁcations and improved quantiﬁcations as an unbiased
detection of proteins and information on some of their structural
qualities. The work has shown novel information on the differences of
different layers of cartilage of value in understanding changes in early
pathology.
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VERIFICATION OF POTENTIAL DISEASE BIOMARKERS IN
MESENCHYMAL STEM CELLS FROM OSTEOARTHRITIS PATIENTS BY
SELECTED REACTION MONITORING ASSAYS
J. Lamas 1, E. Camafeita 2, E. Calvo 2, P. Tornero-Esteban 1, J. Lopez 2,
B. Fernandez-Gutierrez 1. 1Hosp. Clinico San Carlos, Madrid, Spain;
2CNIC, Madrid, Spain
Purpose: To verify the potential role of the proteins which were found
regulated in Bone Marrow-Mesenchymal Stem Cells (BM-MSCs) iso-
lated from OA patients using Selected Reaction Monitoring (SRM)
assays.
Methods: BM aspirates were obtained from the femoral channel of two
OA patients (age: 52 and 89 years) and from three subjects without OA
(mean age 73.3 years, range 47-90) at the time of orthopedic surgery.
Protein extracts (150mg) of BM-MSCs were obtained by standard
methods. Proteins were electrophoresed and after Coomassie blue
staining three consecutive bands (8 x 2mm)were cut out and incubated
with acetonitrile and 10 mM DTT. After several acetonitrile washes
bands were trypsinized with sequencing grade porcine trypsin. Protein
extracts were ﬁnally analyzed by SRM assays performed performed on
an hybrid triple-quadrupole mass spectrometers that enable the mul-
tiplexed, efﬁcacious ﬁltering of selected peptide sequences derived
from speciﬁc proteins of interest. The statistical comparison of the OA
and control groups was performed based on Student's t-test. Values
with p < 0.05 were considered signiﬁcant.Results: Using SRM multiplexed analysis we have validated the differ-
ential expression of potential protein biomarkers in BM-MSCs from OA
patients. These proteins were either metabolic enzymes (cathepsin B
chain B and dihydropyrimidinaselike 2 variant) or proteins related to
cytoskeleton and cell motility (tubulin [[Unsupported Character -
Symbol Font a]]6, Lcaldesmon II and destrin isoform B). SRM enabled
the precise analysis of speciﬁc isoforms beyond commercial antibody-
based assays, that usually analyze several protein isoforms
simultaneously.
Conclusions: Using SRM multiplexed analysis we have validated the
differential expression of potential protein biomarkers in BM-MSCs
from OA patients and reinforced the hypothesized preactivation of
these cells by signaling events produced by the subchondral bone. In
addition we also corroborate the feasibility of using SRM for the mul-
tiplexed identiﬁcation and quantitation of biomarker sets in clinically
relevant samples with high sensitivity and speciﬁcity.
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A RANDOMISED CONTROLLED TRIAL OF CEMENTED VERSUS
CEMENTLESS FIXATION IN OXFORD UNICOMPARTMENTAL KNEE
REPLACEMENT IN THE TREATMENT OF MEDIAL GONARTHROSIS
USING RADIOSTEREOMETRIC ANALYSIS
B.J. Kendrick, N.J. Bottomley, H.S. Gill, W.F. Jackson, C.A. Dodd,
A.J. Price, D.W. Murray. Univ. of Oxford, Oxford, United kingdom
Purpose: The cemented Oxford Unicompartmental Knee Replace-
ment (UKR) has been proven to have excellent survivorship at 10
years and a low polyethylene wear rate at 20 years. Although these
studies suggest that a cemented Oxford UKR is a deﬁnitive device for
medial gonarthrosis there is a concern that cemented ﬁxation may
not be viable in the very long term. There is a developing trend for
earlier surgical intervention in gonarthrosis and there has been an
increase in the use of arthroplasty in younger patients. Therefore, the
potential of biological ﬁxation providing very long term survival is
attractive. Hydroxyapatite coated porous titanium has been shown to
be effective in hip arthroplasty, but much less so in knee arthroplasty
due to the differing surface geometries and loads across the joints.
The Oxford UKR differs from other implants by having a fully
congruent, mobile bearing. Therefore, the forces across the implant/
bone interface are nearly entirely compressive, suggesting that
hydroxyapatite may provide effective ﬁxation. Radiostereometric
Analysis (RSA) has been shown to be highly accurate and is the gold
standard for predicting long term survivorship using early migration
data. The purpose of this study is to measure the migration of each
ﬁxation method (cemented and cementless) to predict the likely
long-term survivorship.
Methods: Patients with bone-on-bone medial gonarthrosis who were
to undergo Oxford UKR were randomised to receive either a cemented
or cementless prosthesis. With the exception of the ﬁxation method
each operation was identical. At surgery RSA tantalum markers were
inserted into the distal femur and proximal tibia. Both groups had
identical post-operative care with mobilisation as soon as tolerated.
Each patient underwent RSA stereoradiographs post-operatively and at
3, 6, 12 and 24 months and screened ﬂuoroscopy of the tibial implant/
bone interface postoperatively and annually. All images were analysed
using Model-based RSA (Medis Specials, Leiden, Netherlands) and
migrationwas measured for translation along each of the three cardinal
axes and rotations around each of those axes. In addition, the Oxford
Knee Score (OKS) was completed pre-operatively and at annual review.
Ethical approval was obtained.
Results: Patients (10 male & 11 female, mean age 65.2 years)
received a cemented implant and 22 patients (13 male & 9 female,
mean age 67.6 years) received a cementless implant. At two years
there was no difference in any translation or rotation for the
femoral component. Maximum Total Point Motion (MTPM) was
0.96 mm for cemented components and 0.87 mm for cementless
components. In contrast, tibial migration showed a signiﬁcant
difference (p¼0.01, t-test) for subsidence at two years. The differ-
ence was established in the ﬁrst six months post-operatively with
no difference in subsidence between ﬁxation methods in the
second post-operative year
There was no difference in any other translation or rotation. The MTPM
was 0.67 mm for cemented components and 0.85 for cementless
components, with no signiﬁcant increase after three months.
